Editors note:Brooks Bell is the founder and CEO of her eponymous brand consulting firm.
RALEIGH A year ago, I was diagnosed with stage 3 colon cancer. Its been a tough year: 6 months of surgery and chemotherapy, followed by intense health recovery. I have made dramatic changes to my diet, fitness routine, and stress. This month, I received the news Ive been fantasizing about all year: Im cancer-free. A groundbreaking blood test determined that there is not a single molecule of my tumor cells currently in my blood. That, combined with a clear CT scan, means that there is a 95% chance that my cancer is gone and wont return. I am overjoyed.
When I received the news, Jes and I were just waking up in the Dominican Republic after celebrating our 21st anniversary together. I burst into tears of joy, and felt the burden of uncertainty lifting off my chest. It was a surreal moment. Id gotten accustomed to clawing back my health, questioning feelings of wellbeing.It was easy to imagine being one of the unlucky ones who has the cancer come back and spread (after all, I was already unlucky enough to get cancer in the first place).
This is what makes cancer so hard for many: even when youre done with your treatment, it takes years to fully relax again because up until now our existing technology has prevented us from knowing if the treatment was truly successful.
Not anymore.
The molecular test that I took is a cutting-edge technology calledNatera. It gives cancer patients personalized testing that involves doing ultra-deep DNA sequencing on your tumor cells, and then matching those to your blood to see if they are still floating around in your body.
It just got FDA breakthrough status in May, and I was the first patient at Duke Cancer Center to receive it.
I believe this test may be part of a paradigm shift in the cancer industry. Its a perfect example of the promise of personalized medicine and machine learning. It is going to give patients clear insight on whether their treatment has been successful, and maybe even if chemotherapy is even necessary for them. Its pretty incredible, and I am so lucky to be able to benefit from it. Go Duke! Go Natera!
Brooks Bells new cause. (Brooks Bell image)
I will be celebrating toasting my health and the50 Colonoscopies Under 50 honorees with my friends and supporters at The Colonoscopy Gala on Feb. 28 at CAM Raleigh. I would love for you to be there with me (especially if you are based in NC).
This may be the first ever Colonoscopy Gala in the history of time. A colonoscopy is the most effective way to protect yourself from colon cancer, and it deserves a night to be celebrated.
Itll be an evening to remember. We will have asuper talented chefdoing a five-course seated dinner for us, and you may be able to even get bring home a one-of-a-kind street-artist designedTushy Ottoman..
And of course, its for a good cause; all proceeds go to the astonishingly underfunded Colorectal Cancer Alliance.
Tickets are $175 each, and are available until Feb. 17. RSVP or donate here.
Brooks Bell: I finished my chemo treatment, feeling fantastic
Six months after cancer diagnosis, Brooks Bell appoints successor to run her brand consulting firm
Go here to see the original:
Brooks Bell: 'Groundbreaking blood test determined there is 95% chance my cancer is gone and won't return' - WRAL Tech Wire
- Managing the tsunami of data and adopting AI technology to create precision care - Philips - June 3rd, 2025
- Rethinking University Research: Innovating the Innovation Ecosystem to Support Life Sciences and Personalized Medicine - The National Law Review - June 3rd, 2025
- Future Therapeutic Directions: Emerging Approaches in PV Management - Targeted Oncology - June 3rd, 2025
- From precision interventions to precision health - Nature - June 3rd, 2025
- How Cloud Computing and AI are Shaping Life Sciences with Pranav Joshi of Merck - Emerj Artificial Intelligence Research - June 3rd, 2025
- Personalized Health Data: The Future of Longevity and Wellness - WorldHealth.net - June 3rd, 2025
- All-Cause Mortality Risk 66% Higher in People with Both Hypertension and T2D - Inside Precision Medicine - June 3rd, 2025
- Newborns May Have Window for In Vivo Gene Therapy - Inside Precision Medicine - June 3rd, 2025
- After PARP Inhibitors, What Will Be the Next Precision Medicine Advance in Ovarian Cancer? - Precision Medicine Online - June 3rd, 2025
- Personalized Medicine Biomarkers Market Exclusive Report on the Latest Revenue and Future Scope - openPR.com - June 3rd, 2025
- Enhertu Established as Second-Line Standard in HER2-Positive Gastric Cancer in Phase III Study - Precision Medicine Online - June 3rd, 2025
- The Integration of Artificial Intelligence Into Precision Medicine for Neuro-Oncology: Ethical, Clinical, and Nursing Implications in Immunotherapy... - June 3rd, 2025
- Precision Oncology: The Future of Personalized Cancer Treatment - Cancer Health - June 3rd, 2025
- Personalized medicine could transform healthcare - PMC - April 24th, 2025
- Genomic medicine and personalized treatment: a narrative review - April 24th, 2025
- Podcast: Ochre Bios Approach To Precision Medicine In Liver Treatment - insights.citeline.com - April 24th, 2025
- Reinforcement Learning in Personalized Medicine: A Comprehensive Review of Treatment Optimization Strategies - Cureus - April 24th, 2025
- Evolving Biomarkers: Charting the Future of Precision Medicine - MarketScale - April 24th, 2025
- Next Generation Tissue Biomarkers Market Size Report 2030 - Grand View Research - April 24th, 2025
- City of Hope Research on Artificial Intelligence (AI), Precision Medicine, Immunotherapies and Other Topics to be Presented at American Association of... - April 24th, 2025
- What the Newest mRNA Vaccines Could Do Beyond COVID - News-Medical - April 24th, 2025
- Opinion: Where public health ends and personalised medicine begins - Pulse+IT News - April 24th, 2025
- Crohns Disease Treatment Market to Reach $5.9 Billion by 2034, Driven by Biologics & Precision Medicine - Global Banking | Finance | Review - April 24th, 2025
- The Role of High Throughput Screening in Precision Medicine and Market Growth In New Report - WhaTech - April 24th, 2025
- Antiviral Chewing Gum May Prevent Flu and Herpes Transmission - Inside Precision Medicine - April 14th, 2025
- Wisconsin's role in the next advances in health care - BizTimes - April 14th, 2025
- The Future of Pulmonary Fibrosis Management: Precision Medicine, Biomarkers and AI - Managed Healthcare Executive - April 14th, 2025
- Leading Driver In The Jetrea Market 2025: Rise Of Personalized Medicine Fueling Growth - EIN News - March 9th, 2025
- Personalized Medicine Market Overview 2024-2025 & 2030: Oncology, Neurology, and Cardiology Lead Expansion, ext-Generation Sequencing and AI... - March 9th, 2025
- Innovations in core-shell nanoparticles advance drug delivery and precision medicine - Phys.org - March 9th, 2025
- Personalized Medicine: Motivation, Challenges and Progress - February 24th, 2025
- Healthcare innovations in predictive analytics, AI, and personalized medicine - HealthLeaders Media - February 24th, 2025
- Healthcare innovations in predictive analytics, AI, and personalized medicine - Fast Company - February 24th, 2025
- Artificial Intelligence (Ai) In Precision Medicine Market to See Robust Growth from USD 2.14 Billion to USD - EIN News - February 24th, 2025
- BMY: 3 Precision Medicine Stocks That Could Transform Healthcare - StockNews.com - February 24th, 2025
- Cracking Cancers Code: How Genetic Testing Is Changing the Treatment Game - geneonline - February 24th, 2025
- Curt Medeiros on Revolutionizing Precision Medicine and Scaling Ovation - Madrona Venture Group - January 6th, 2025
- Personalized medicine: The pros, cons and concerns - New Atlas - November 16th, 2024
- Precision Medicine, AI, and the Future of Personalized Health Care - November 16th, 2024
- Why precision medicine results in more effective health care, treatment plans - The Business Journals - November 16th, 2024
- Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer - Inside Precision Medicine - November 16th, 2024
- More Precise Classifications of NonClear Cell RCC Are Required to Improve Personalized Treatment - OncLive - September 13th, 2024
- Bahrain aims to provide residents with personalized healthcare - Healthcare IT News - September 13th, 2024
- Precision Medicine Market Is Expected To Reach Revenue Of - GlobeNewswire - September 13th, 2024
- New Graduates Leverage Genomics Education in Clinical and Research Settings - University of Colorado Anschutz Medical Campus - June 20th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022